2023 Highlights
- In 2023, 13% of cases were due to P. vivax, up from only 3% in 2022
- Most cases reported travel to countries in West Africa, with the top destinations of Nigeria, Liberia, and Sierra Leone
- Of the 65 cases with known country of birth, only four cases were born in the United States
In 2023, 90 cases (1.6 per 100,000 population) were reported, an increase from 72 cases in 2022. Seventy (78%) cases were identified with P. falciparum, twelve (13%) with P. vivax, and five (6%) with P. ovale. In three cases (3%), the testing performed was unable to identify a species. The median age of cases was 38 years (range, 2 to 83). Of the 88 cases with known race, 74 (84%) were Black, four (5%) were white, three (3%) were Asian, and seven (8%) identified as other race. All 90 cases were Minnesota residents at the time of their illness, 68 (76%) of whom resided in the seven-county Twin Cities metropolitan area. Of the 65 cases with known country of birth, four (6%) were born in the United States. Exposure and travel information was available for all cases, and while 80 (89%) cases likely acquired malaria in Africa, seven cases reported travel to Central and South America, and three patients reported travel to Asia. Twenty-seven countries were considered possible exposure locations for malaria infections, a majority of which were in Africa including Nigeria (16), Liberia (13), Sierra Leone (12), Togo (8), and Guinea (6) as well as several other countries in sub-Saharan Africa.